Key Takeaway: The EveryLife Foundation for Rare Diseases aims to empower the rare disease patient community by advocating for impactful legislation and policies. Their focus is on advancing equitable access to lifesaving diagnoses, treatments, and cures. The foundation emphasizes the importance of science-driven initiatives in improving patient outcomes.
Price reaction · baseline $3.57 (2023-09-22T16:35:00.000Z) · hit during market hours · 14 other OVID headline(s) in the window, move may be shared
day 0 close · peak
+2%
Market Sentiment Analysis
POSITIVE FACTORS
Empowers the rare disease patient community.
Advocates for science-driven legislation.
Focuses on equitable access to treatments.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+622%
120-day peak, hindsight
Typical move
2.4%
average across 3 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Full Press Release Details
The EveryLife Foundation for Rare Diseases is dedicated to empowering the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures.
Visit Site »
Frequently Asked Questions
What is the mission of the EveryLife Foundation?
The EveryLife Foundation aims to empower the rare disease patient community through advocacy.
How does the EveryLife Foundation support patients?
It advocates for science-driven legislation and equitable access to treatments.
What does the foundation focus on?
The foundation focuses on advancing access to lifesaving diagnoses and cures.
Biotech snapshot
Cash runway
$166M liquidity · $5M/mo burn
~33 mo
Minimal dilution risk
Catalyst track record
+622%
best trade around OVID's most recent catalyst
Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for OVID.